Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.

We talk Ozempic, Wegovy and Mounjaro. A number of studies have shown the amazing weight loss potential of a new group of ...

Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

And based on the data so far, amycretin looks even more impressive than Wegovy and Eli Lilly's Zepbound, the two top-selling weight loss drugs. In a 72-week study, Zepbound's mean weight loss was ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Mitolyn: A Positive Alternative in the Wegovy vs. Ozempic Weight Loss Debate Mitolyn is a natural weight loss supplement designed to support weight management through science-backed ingredients. It ...